Literature DB >> 22835522

Lipid phosphate phosphatase (LPP3) and vascular development.

H Ren1, M Panchatcharam, P Mueller, D Escalante-Alcalde, A J Morris, S S Smyth.   

Abstract

Lipid phosphate phosphatases (LPP) are integral membrane proteins with broad substrate specificity that dephosphorylate lipid substrates including phosphatidic acid, lysophosphatidic acid, ceramide 1-phosphate, sphingosine 1-phosphate, and diacylglycerol pyrophosphate. Although the three mammalian enzymes (LPP1-3) demonstrate overlapping catalytic activities and substrate preferences in vitro, the phenotypes of mice with targeted inactivation of the Ppap2 genes encoding the LPP enzymes reveal nonredundant functions. A specific role for LPP3 in vascular development has emerged from studies of mice lacking Ppap2b. A meta-analysis of multiple, large genome-wide association studies identified a single nucleotide polymorphism in PPAP2B as a novel predictor of coronary artery disease. In this review, we will discuss the evidence that links LPP3 to vascular development and disease and evaluate potential molecular mechanisms. This article is part of a Special Issue entitled Advances in Lysophospholipid Research.
Copyright © 2012 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22835522      PMCID: PMC3683602          DOI: 10.1016/j.bbalip.2012.07.012

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  96 in total

1.  Cloning and characterization of two human isozymes of Mg2+-independent phosphatidic acid phosphatase.

Authors:  M Kai; I Wada; S i Imai; F Sakane; H Kanoh
Journal:  J Biol Chem       Date:  1997-09-26       Impact factor: 5.157

2.  Induction of apoptosis by sphingosine, sphinganine, and C(2)-ceramide in human colon cancer cells, but not by C(2)-dihydroceramide.

Authors:  Eun Hyun Ahn; Joseph J Schroeder
Journal:  Anticancer Res       Date:  2010-07       Impact factor: 2.480

3.  Release of sphingosine-1-phosphate from human platelets is dependent on thromboxane formation.

Authors:  T Ulrych; A Böhm; A Polzin; G Daum; R M Nüsing; G Geisslinger; T Hohlfeld; K Schrör; B H Rauch
Journal:  J Thromb Haemost       Date:  2011-04       Impact factor: 5.824

4.  Human type 2 phosphatidic acid phosphohydrolases. Substrate specificity of the type 2a, 2b, and 2c enzymes and cell surface activity of the 2a isoform.

Authors:  R Roberts; V A Sciorra; A J Morris
Journal:  J Biol Chem       Date:  1998-08-21       Impact factor: 5.157

5.  Lipid phosphate phosphohydrolase type 1 (LPP1) degrades extracellular lysophosphatidic acid in vivo.

Authors:  Jose L Tomsig; Ashley H Snyder; Evgeny V Berdyshev; Anastasia Skobeleva; Chifundo Mataya; Viswanathan Natarajan; David N Brindley; Kevin R Lynch
Journal:  Biochem J       Date:  2009-05-01       Impact factor: 3.857

6.  Deafness and stria vascularis defects in S1P2 receptor-null mice.

Authors:  Mari Kono; Inna A Belyantseva; Athanasia Skoura; Gregory I Frolenkov; Matthew F Starost; Jennifer L Dreier; Darcy Lidington; Steffen-Sebastian Bolz; Thomas B Friedman; Timothy Hla; Richard L Proia
Journal:  J Biol Chem       Date:  2007-02-06       Impact factor: 5.157

7.  Functional invalidation of the autotaxin gene by a single amino acid mutation in mouse is lethal.

Authors:  Gilles Ferry; Adeline Giganti; Francis Cogé; Fabien Bertaux; Kader Thiam; Jean A Boutin
Journal:  FEBS Lett       Date:  2007-07-03       Impact factor: 4.124

8.  Murine lipid phosphate phosphohydrolase-3 acts as a cell-associated integrin ligand.

Authors:  Joseph O Humtsoe; Rodney A Bowling; Shu Feng; Kishore K Wary
Journal:  Biochem Biophys Res Commun       Date:  2005-09-30       Impact factor: 3.575

9.  Mice with targeted inactivation of ppap2b in endothelial and hematopoietic cells display enhanced vascular inflammation and permeability.

Authors:  Manikandan Panchatcharam; Abdel K Salous; Jason Brandon; Sumitra Miriyala; Jessica Wheeler; Pooja Patil; Manjula Sunkara; Andrew J Morris; Diana Escalante-Alcalde; Susan S Smyth
Journal:  Arterioscler Thromb Vasc Biol       Date:  2014-02-06       Impact factor: 8.311

10.  Plasma levels of sphingosine 1-phosphate are strongly correlated with haematocrit, but variably restored by red blood cell transfusions.

Authors:  Samy Selim; Manjula Sunkara; Abdelghaffar K Salous; Steve W Leung; Evgeny V Berdyshev; Alison Bailey; Charles L Campbell; Richard Charnigo; Andrew J Morris; Susan S Smyth
Journal:  Clin Sci (Lond)       Date:  2011-12       Impact factor: 6.124

View more
  27 in total

1.  Regulation of PLPP3 gene expression by NF-κB family transcription factors.

Authors:  Guogen Mao; Susan S Smyth; Andrew J Morris
Journal:  J Biol Chem       Date:  2019-07-30       Impact factor: 5.157

2.  Source and role of intestinally derived lysophosphatidic acid in dyslipidemia and atherosclerosis.

Authors:  Mohamad Navab; Arnab Chattopadhyay; Greg Hough; David Meriwether; Spencer I Fogelman; Alan C Wagner; Victor Grijalva; Feng Su; G M Anantharamaiah; Lin H Hwang; Kym F Faull; Srinivasa T Reddy; Alan M Fogelman
Journal:  J Lipid Res       Date:  2015-02-02       Impact factor: 5.922

3.  Crystal structure of lipid phosphatase Escherichia coli phosphatidylglycerophosphate phosphatase B.

Authors:  Junping Fan; Daohua Jiang; Yan Zhao; Jianfeng Liu; Xuejun Cai Zhang
Journal:  Proc Natl Acad Sci U S A       Date:  2014-05-12       Impact factor: 11.205

4.  Different origins of lysophospholipid mediators between coronary and peripheral arteries in acute coronary syndrome.

Authors:  Makoto Kurano; Kuniyuki Kano; Tomotaka Dohi; Hirotaka Matsumoto; Koji Igarashi; Masako Nishikawa; Ryunosuke Ohkawa; Hitoshi Ikeda; Katsumi Miyauchi; Hiroyuki Daida; Junken Aoki; Yutaka Yatomi
Journal:  J Lipid Res       Date:  2016-12-22       Impact factor: 5.922

5.  Role of lipid phosphate phosphatase 3 in human aortic endothelial cell function.

Authors:  Zahia Touat-Hamici; Henri Weidmann; Yuna Blum; Carole Proust; Hervé Durand; Francesca Iannacci; Veronica Codoni; Pauline Gaignard; Patrice Thérond; Mete Civelek; Sonia A Karabina; Aldons J Lusis; François Cambien; Ewa Ninio
Journal:  Cardiovasc Res       Date:  2016-09-30       Impact factor: 10.787

Review 6.  Autotaxin: structure-function and signaling.

Authors:  Anastassis Perrakis; Wouter H Moolenaar
Journal:  J Lipid Res       Date:  2014-02-18       Impact factor: 5.922

7.  Mechanosensitive PPAP2B Regulates Endothelial Responses to Atherorelevant Hemodynamic Forces.

Authors:  Congqing Wu; Ru-Ting Huang; Cheng-Hsiang Kuo; Sandeep Kumar; Chan Woo Kim; Yen-Chen Lin; Yen-Ju Chen; Anna Birukova; Konstantin G Birukov; Nickolai O Dulin; Mete Civelek; Aldons J Lusis; Xavier Loyer; Alain Tedgui; Guohao Dai; Hanjoong Jo; Yun Fang
Journal:  Circ Res       Date:  2015-06-01       Impact factor: 17.367

Review 8.  Arguing the case for the autotaxin-lysophosphatidic acid-lipid phosphate phosphatase 3-signaling nexus in the development and complications of atherosclerosis.

Authors:  Susan S Smyth; Paul Mueller; Fanmuyi Yang; J Anthony Brandon; Andrew J Morris
Journal:  Arterioscler Thromb Vasc Biol       Date:  2014-01-30       Impact factor: 8.311

9.  Lipid phosphate phosphatase 3 negatively regulates smooth muscle cell phenotypic modulation to limit intimal hyperplasia.

Authors:  Manikandan Panchatcharam; Sumitra Miriyala; Abdelghaffar Salous; Jessica Wheeler; Anping Dong; Paul Mueller; Manjula Sunkara; Diana Escalante-Alcalde; Andrew J Morris; Susan S Smyth
Journal:  Arterioscler Thromb Vasc Biol       Date:  2012-10-25       Impact factor: 8.311

10.  Compartmentalizing the embryo: lipids and septate junction mediated barrier function.

Authors:  Kristina E Ile; Andrew D Renault
Journal:  Fly (Austin)       Date:  2012-12-06       Impact factor: 2.160

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.